Interaction between FAK/αB-crystalline is important for viability of the glioblastoma cells
DOI:
https://doi.org/10.1590/Keywords:
Glioblastoma, FAK, αB-crystalline, Peptides, Protein interactionAbstract
Glioblastoma multiforme is a tumor of the central nervous system. Focal Adhesion Kinase (FAK) and αB-crystalline are two proteins involved in glioblastoma development. In this study, we investigated whether the FAK/αB-crystalline interaction is important for glioblastoma cells, we aimed to investigate the interaction of these two proteins in the glioblastoma multiforme cell line U87-MG. Two peptides named FP01 peptide (derived from αB-crystalline) and FP02 peptide (derived from FAK) were synthesized for this study. Treatment of U87-MG with the peptides FP01 and FP02 in the concentration at 50 µM reduced the viability cellular to around 41% and 51%, respectively. Morphological alterations in the cells treated with the peptides when compared to the control were observed. This study suggests that the interaction between FAK and αB-crystalline is important for the viability of glioblastoma cells.
Downloads
References
Chang JE, Khuntia D, Robins HI, Mehta MP. Radiotherapy and radiosensitizers in the treatment of glioblastoma multiforme. Clin Adv Hematol Oncol. 2007;5(11):894-902.
Cui W, Aouidate A, Wang S, Yu O, Li Y, Yuan S. Discovering Anti-Cancer Drugs via Computational Methods. Front Pharmacol. 2020;11:1-20.
Dallavalle S, Dobricic V, Lazzarato L, Gazzano E, Machuqueiro M, Pajeva I. Improvement of conventional anti-cancer drugs as new tools against multidrug-resistant tumors. Drug Resistance Updates. 2020;50:100682.
Dunn GP, Rinne ML, Wykosky J, Genovese G, Quayle SN, Dunn IF. Emerging insights into the molecular and cellular basis of glioblastoma. Genes Dev. 2012;26(8):756-784.
Eghtedari M, Porzani SJ, Nowruzi B. Anticancer potential of natural peptides from terrestrial and marine environments: a review. Phytochem Lett. 2021;42: 87-103.
Goplen D, Bougnaud S, Rajcevic U, Boe SO, Skaftnesmo KO, Voges J et al. αB-crystallin is elevated in highly infiltrative apoptosis-resistant glioblastoma cells. Am J Pathol. 2010;177(4):1618-1628.
Haskell H, Natarajan M, Hecker TP, Ding Q, Stewart J Jr, Grammer JR, et al. Focal adhesion kinase is expressed in the angiogenic blood vessels of malignant astrocytic tumors in vivo and promotes capillary tube formation of brain microvascular endothelial cells. Clin Cancer Res. 2003;9(6):2157-2165.
Karcher S, Steiner HH, Ahmadi R, Zoubaa S, Vasvari G, Bauer H, et al. Different angiogenic phenotypes in primary and secondary glioblastomas. Int J Cancer. 2006;118(9):2182-2189.
Kleihues P, Soylemezoglu F, Schäuble B, Scheithauer BW, Burger PC. Histopathology, classification, and grading of gliomas. Glia. 1995;15(3):211-221.
Liu T, Peng F, Cao X, Liu F, Wang Q, Liu L et al. Design, synthesis, antibacterial activity, antiviral activity, and mechanism of myricetin derivatives containing a quinazolinone moiety. ACS Omega. 2021;6(45):30826-30833.
Mcilwain DR, Berger T, Mak TW. Caspase Functions in Cell Death and Disease. Cold Spring Harbor Perspect Biol. 2013;5(4):8656-8656 11.
Natarajan M, Hecker TP, Gladson CL. FAK signaling in anaplastic astrocytoma and glioblastoma tumors. Cancer J. 2003;9(2):126-133.
Pereira MBM, Santos AM, Gonçalves DC, Cardoso AC, Consonni SR, Gozzo FC, et al. αB-crystallin interacts with and prevents stress-activated proteolysis of focal adhesion kinase by calpain in cardiomyocytes. Nat Commun. 2014;5:5159-5175.
Riedl S, Zweytick D, Lohner K. Membrane-active host defense peptides - Challenges and perspectives for the development of novel anticancer drugs. Chemistry And Physics of Lipids. 2011;164(8):766-781.
Robins HI, Chang S, Butowski N. Therapeutic advances for glioblastoma multiforme: current status and future prospects. Curr Oncol Rep. 2007;9:66-70.
Schröder R, Bien K, Kott R, Meyers I, Vössing R. The relationship between Ki-67 labeling and mitotic index in gliomas and meningiomas: demonstration of the variability of the intermitotic cycle time. Acta Neuropathol. 1991;82(5):389-394.
Schultz S, Pinsky GS, Wu NC, Chamberlain MC, Rodrigo AS, Martin SE. Fine needle aspiration diagnosis of extracranial glioblastoma multiforme: Case report and review of the literature. Cytojournal. 2005;2:1-6.
Segura-Campos M, Guerrero LC, Betancur D, Hernandez-Escalante VM. Bioavailability of Bioactive Peptides. Food Rev Int. 2011;27(3):213-226.
Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, Squire J et al. Identification of a cancer stem cell in human brain tumors. Cancer Res. 2003;63(18):5821-5828.
Stupp R, Hegi ME, van den Bent MJ. European Organization for Research and Treatment of Cancer Brain Tumor and Radiotherapy, G and National Cancer Institute of Canada Clinical Trials, G. Oncologist. 2006;11:165-180.
Trinidad-Calderón PA, Varela-Chinchilla CD, García-Lara S. Natural Peptides Inducing Cancer Cell Death: mechanisms and properties of specific candidates for cancer therapeutics. Molecules. 2021;26(24):7453-7474.
Wang C, Dong S, Zhang L, Zhao Y, Huang L, Gong X, et al. Cell surface binding, uptaking and anticancer activity of L-K6, a lysine/leucine-rich peptide, on human breast cancer MCF-7 cells. Sci Rep. 2017;7:8293-8306.
Wechsler-Reya R, Scott MP. The developmental biology of brain tumors. Ann Rev Neurosci. 2001;24:385-428.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Brazilian Journal of Pharmaceutical Sciences

This work is licensed under a Creative Commons Attribution 4.0 International License.
All content of the journal, except where identified, is licensed under a Creative Commons attribution-type BY.
The on-line journal has open and free access.